Coston, Mc Isaac & Partners Northwest Biotherapeutics Inc Call Options Transaction History
Coston, Mc Isaac & Partners
- $298 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NWBO
# of Institutions
13Shares Held
674KCall Options Held
0Put Options Held
0-
Moloney Securities Asset Management, LLC462KShares$120,1750.02% of portfolio
-
Opus Capital Group, LLC60.2KShares$15,6390.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY35KShares$9,1000.0% of portfolio
-
Ethos Financial Group, LLC King Of Prussia, PA23.7KShares$6,1620.0% of portfolio
-
Mai Capital Management20KShares$5,2000.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $270M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...